Zhao, Bing
Zheng, Huiwen
Timm, Juliano
Song, Zexuan
Pei, Shaojun
Xing, Ruida
Guo, Yajie
Ma, Ling
Li, Feina
Li, Qing
Li, Yan
Huang, Lin
Teng, Chong
Wang, Ni
Gupta, Aastha
Juneja, Sandeep
Huang, Fei
Zhao, Yanlin
Ou, Xichao
Funding for this research was provided by:
Beijing Natural Science Foundation (7224328)
Natural Science Foundation of Gansu Province (22JR5RA712)
Science and Technology Plan Project of Gansu Province (21JR11RA184)
National Key R&D Program of China (2022YFC2305204)
Article History
Received: 16 October 2023
Accepted: 20 April 2024
First Online: 3 May 2024
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of China CDC (202223). Patient consent was waived due to all isolates used in this study were from previous drug-resistance surveillance (DRS) work, and no additional data and specimens were collected. Each patient signed an informed consent form during the routine DRS.
: All authors have reviewed and approved the manuscript for publication.
: The authors declare no competing interests.